Serious adverse events · patients with laparoscopic cholecystectomy.
It is very uncertain whether miniport laparoscopic cholecystectomy changes serious adverse events compared with standard port laparoscopic cholecystectomy (very low certainty).
1 finding from 1 review
Serious adverse events (proportion) · patients with oesophageal cancer
It is very uncertain whether laparoscopic changes serious adverse events (proportion) compared with open transhiatal oesophagectomy (very low certainty).
1 finding from 1 review
SAEs · participants with obesity
The review found no eligible studies for this question.
1 finding from 1 review
SAEs · participants with obesity
The review found no eligible studies for this question.
1 finding from 1 review
Serious adverse events · Patients with gastro‐oesophageal reflux disease (GORD) in adults
It is very uncertain whether laparoscopic fundoplication changes serious adverse events compared with medical management (very low certainty).
1 finding from 1 review
SAEs · participants with obesity
The review found no eligible studies for this question.
1 finding from 1 review
SAEs · participants with obesity
1 finding from 1 review
Serious adverse events (proportion) · patients with pancreatic cancer
It is very uncertain whether laparoscopic distal pancreatectomy changes serious adverse events (proportion) compared with open distal pancreatectomy (very low certainty).
1 finding from 1 review
Serious adverse events · people undergoing laparoscopic cholecystectomy.
It is very uncertain whether summary of findings table ‐ Intraperitoneal local anaesthetic changes serious adverse events compared with control (very low certainty).
1 finding from 1 review
Serious adverse events · patients with laparoscopic cholecystectomy.
It is very uncertain whether low pressure changes serious adverse events compared with standard pressure pneumoperitoneum (very low certainty).
1 finding from 1 review
Serious adverse events · patients with people undergoing laparoscopic cholecystectomy
1 finding from 1 review
Serious adverse events · patients with people undergoing laparoscopic cholecystectomy.
It is very uncertain whether local anaesthetic wound infiltration changes serious adverse events compared with no local anaesthetic wound infiltration (very low certainty).
1 finding from 1 review
Intervention not reported
Serious adverse events · people undergoing laparoscopic cholecystectomy.
1 finding from 1 review
Serious adverse events · people undergoing laparoscopic cholecystectomy.
It is very uncertain whether fewer‐than‐four ports changes serious adverse events compared with four ports (very low certainty).
1 finding from 1 review
Intervention not reported
Serious adverse events · patients undergoing laparoscopic cholecystectomy.
It is very uncertain whether the intervention changes serious adverse events (very low certainty).
1 finding from 1 review
Serious adverse events · patients with laparoscopic cholecystectomy.
It is very uncertain whether day‐surgery changes serious adverse events compared with overnight stay surgery (very low certainty).
1 finding from 1 review
Serious adverse events · people with biliary colic
It is very uncertain whether early changes serious adverse events compared with delayed laparoscopic cholecystectomy (very low certainty).
1 finding from 1 review
Serious adverse events · people with mild acute gallstone pancreatitis
It is very uncertain whether early changes serious adverse events compared with delayed laparoscopic cholecystectomy (very low certainty).
1 finding from 1 review
Short‐term serious adverse events (SAEs) · adults undergoing intra‐ and transperitoneal laparoscopic procedures
It is very uncertain whether summary of findings table ‐ Deep neuromuscular blockade (NMB) changes short‐term serious adverse events (SAEs) compared with moderate NMB (very low certainty).
1 finding from 1 review
Short‐term serious adverse events (SAEs) · adults undergoing intra‐ and transperitoneal laparoscopic procedures
It is very uncertain whether summary of findings table ‐ Deep neuromuscular blockade (NMB) changes short‐term serious adverse events (SAEs) compared with shallow NMB (very low certainty).
1 finding from 1 review